NCT04469556 2026-02-20
PASS-01
University Health Network, Toronto
Phase 2 Completed
Clinical Trials
4 trialsNCT07230301 2025-11-17
Adebrelimab Infusion Plus Standard Care for Pancreatic Cancer With Pleural or Peritoneal Effusions
Jinling Hospital, China
Phase 2 Not yet recruiting
NCT05969171 2025-07-30
A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Fudan University
Phase 2 Recruiting
NCT06690528 2024-11-15
SONAR
Azienda Ospedaliera di Padova
Phase 2 Recruiting